Viking Therapeutics Inc (NASDAQ: VKTX) on Thursday, soared 1.44% from the previous trading day, before settling in for the closing price of $23.60. Within the past 52 weeks, VKTX’s price has moved between $18.92 and $81.86.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -55.67%. With a float of $108.97 million, this company’s outstanding shares have now reached $111.57 million.
The extent of productivity of a business whose workforce counts for 36 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Viking Therapeutics Inc (VKTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Viking Therapeutics Inc is 2.94%, while institutional ownership is 73.35%. The most recent insider transaction that took place on Mar 31 ’25, was worth 29,943. In this transaction Director of this company bought 1,240 shares at a rate of $24.15, taking the stock ownership to the 1,240 shares. Before that another transaction happened on Jan 06 ’25, when Company’s President & CEO sold 194,490 for $42.75, making the entire transaction worth $8,313,601. This insider now owns 2,366,570 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -55.67% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Viking Therapeutics Inc (VKTX) is currently performing well based on its current performance indicators. A quick ratio of 33.09 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.01, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -2.11 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
The latest stats from [Viking Therapeutics Inc, VKTX] show that its last 5-days average volume of 4.88 million was superior to 4.52 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 56.67%. Additionally, its Average True Range was 2.39.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 13.45%, which indicates a significant decrease from 61.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.86% in the past 14 days, which was higher than the 81.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.47, while its 200-day Moving Average is $47.72. Now, the first resistance to watch is $24.96. This is followed by the second major resistance level at $25.99. The third major resistance level sits at $27.85. If the price goes on to break the first support level at $22.07, it is likely to go to the next support level at $20.21. Assuming the price breaks the second support level, the third support level stands at $19.18.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
Market capitalization of the company is 2.69 billion based on 112,289K outstanding shares. Right now, sales total 0 K and income totals -109,960 K. The company made 0 K in profit during its latest quarter, and -35,420 K in sales during its previous quarter.
